Amdocs Limited (DOX)

Revance Therapeutics Market Cap

Amdocs has a market cap or net worth of $9.40 billion as of August 1, 2025. Its market cap has decreased by -3.76% in one year.

• Market Cap: 9.40B
• Enterprise Value: 9.86B
• 1-Year Change: -3.76%
• Ranking: #916
• Category: Mid-Cap
• Stock Price: $84.47

Market Cap Chart

Since December 1, 1998, Amdocs's market cap has increased from $2.98B to $9.40B, an increase of 215.59%. That is a compound annual growth rate of 4.40%.

Market Cap History

Date	Market Cap	% Change
Aug 1, 2025	9.46B	-1.58%
Dec 31, 2024	9.61B	-6.81%
Dec 29, 2023	10.31B	-6.11%
Dec 30, 2022	10.98B	17.55%
Dec 31, 2021	9.35B	0.16%
Dec 31, 2020	9.33B	-4.11%
Dec 31, 2019	9.73B	18.48%
Dec 31, 2018	8.21B	-13.15%
Dec 29, 2017	9.45B	10.32%
Dec 30, 2016	8.57B	3.91%
Dec 31, 2015	8.25B	12.82%
Dec 31, 2014	7.31B	10.76%
Dec 31, 2013	6.60B	19.54%
Dec 31, 2012	5.52B	10.79%
Dec 30, 2011	4.98B	-6.02%
Dec 31, 2010	5.30B	-9.36%
Dec 31, 2009	5.85B	56.88%
Dec 31, 2008	3.73B	-48.42%
Dec 31, 2007	7.23B	-9.77%
Dec 29, 2006	8.01B	45.56%
Dec 30, 2005	5.51B	4.16%
Dec 31, 2004	5.29B	8.81%
Dec 31, 2003	4.86B	122.17%
Dec 31, 2002	2.19B	-71.09%
Dec 31, 2001	7.56B	-42.58%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
NVIDIA	4,374.19B
Microsoft	3,814.68B
Apple	3,122.33B
Broadcom	1,423.36B
Taiwan Semiconductor Manufacturing Company	1,004.50B
Oracle	703.89B
Palantir Technologies	374.31B
SAP SE	338.32B